Incorporating genomics into breast and prostate cancer screening: assessing the implications.
about
Risk prediction tools for cancer in primary careThe Human Genome Project, and recent advances in personalized genomicsDo Health Professionals Need Additional Competencies for Stratified Cancer Prevention Based on Genetic Risk Profiling?No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.Constructing Hypothetical Risk Data from the Area under the ROC Curve: Modelling Distributions of Polygenic Risk.Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation CarriersCancer screening and genetics: a tale of two paradigmsHow can polygenic inheritance be used in population screening for common diseases?The KinFact intervention - a randomized controlled trial to increase family communication about cancer historyPublic health genomics and personalized prevention: lessons from the COGS project.Adjusting the frequency of mammography screening on the basis of genetic risk: Attitudes among women in the UK.Maximising the efficiency of clinical screening programmes: balancing predictive genetic testing with a right not to knowAttitudes to incorporating genomic risk assessments into population screening programs: the importance of purpose, context and deliberationGenetic testing and personalized ovarian cancer screening: a survey of public attitudesPrimary care providers' cancer genetic testing-related knowledge, attitudes, and communication behaviors: A systematic review and research agenda.Personalized screening for cancers: should we consider polygenic profiling?Population-Based Precision Cancer Screening: A Symposium on Evidence, Epidemiology, and Next Steps.Managing the ethical challenges of next-generation sequencing in genomic medicine.Predictive or not predictive: understanding the mixed messages from the patient's DNA sequence.Public interest in and acceptability of the prospect of risk-stratified screening for breast and prostate cancer.Communication Among Melanoma Family Members.Health care professionals' attitudes towards population-based genetic testing and risk-stratification for ovarian cancer: a cross-sectional survey.Making Sense of SNPs: Women's Understanding and Experiences of Receiving a Personalized Profile of Their Breast Cancer Risks.Clinical interpretation of pathogenic ATM and CHEK2 variants on multigene panel tests: navigating moderate risk.Disentangling the determinants of interest and willingness-to-pay for breast cancer susceptibility testing in the general population: a cross-sectional Web-based survey among women of Québec (Canada).Women's decision-making regarding risk-stratified breast cancer screening and prevention from the perspective of international healthcare professionals.Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer: A Life-Table Model
P2860
Q26774974-A62A7D03-F157-402D-AC72-A28D217DDFB6Q26861372-DE884098-9163-4349-BACA-158B20129F29Q28084601-1D7D3C9A-8C19-4B4D-92F9-DE8B9E08C7C6Q30374367-1CE4E0F7-15C3-4736-9B86-3ABC0BC1B749Q31064480-901AE622-3509-4FF9-9026-7BF34771BF53Q33614244-2A97AEEA-8AD2-437B-B803-44280ECD3343Q33717364-34AF3AF8-8EAF-48AD-A96C-C2254633A318Q34327946-3365FF92-E4F7-44FA-99EE-6D8548EA1B9FQ34330758-35CE28CA-1C1D-45E2-8B57-2BC9CF29F0E9Q34811135-74188BB8-BF35-4F02-8C7E-7D3C2C050D5CQ35592936-8656EDC2-5A6F-4D49-9E13-7DE12F3A1575Q35959746-76220534-B0B9-4932-8508-746E6280647FQ36027086-B2723F18-F54F-4DE4-8C25-AB2839CB8037Q36086513-2B3A7D25-9581-406D-BA87-6718432A4AA7Q36229139-27FCC356-40F4-495C-B808-DED3B2F055EAQ37333975-543E63D0-ED7D-4311-A29D-E937785AA95EQ37513339-7F777527-997B-452D-BD4A-C1213399E3F7Q38239811-B3209756-60F1-41F2-9B1F-E7CE3F2C1F53Q38945647-17EC2D2A-AB56-4D2F-870E-83FF7501BEAAQ41728154-E0F92E9E-C27A-4614-9EE1-337A6204F266Q46814096-52755CA0-4F7D-4196-8145-7C7EDB5A58CFQ47110015-764A070C-A939-43FD-B7F4-F80E41D3A09EQ47822347-C71D20CD-17E3-43C1-9D27-49AE4587A1ECQ49993491-388A7703-FD94-4CEE-9D52-D8A92E235112Q52682549-C78F8CB3-F3F2-4C4C-8504-4B003FE7C1C9Q55315231-0AE37842-5BD6-4A89-A7FE-D6A924AE9ED1Q57177092-337032AD-617D-4795-884B-C8125D6BF9BC
P2860
Incorporating genomics into breast and prostate cancer screening: assessing the implications.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 February 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Incorporating genomics into br ...... g: assessing the implications.
@en
Incorporating genomics into br ...... g: assessing the implications.
@nl
type
label
Incorporating genomics into br ...... g: assessing the implications.
@en
Incorporating genomics into br ...... g: assessing the implications.
@nl
prefLabel
Incorporating genomics into br ...... g: assessing the implications.
@en
Incorporating genomics into br ...... g: assessing the implications.
@nl
P2093
P2860
P921
P356
P1433
P1476
Incorporating genomics into br ...... g: assessing the implications.
@en
P2093
Alison Hall
Georgios Lyratzopoulos
Hilary Burton
Nina Hallowell
Nora Pashayan
Susmita Chowdhury
P2860
P2888
P304
P356
10.1038/GIM.2012.167
P407
P5008
P577
2013-02-14T00:00:00Z
2013-06-01T00:00:00Z